These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 25672721)

  • 1. [Autoimmune encephalitis-update: roles of autoantibodies in the pathogenesis].
    Tanaka K
    Rinsho Shinkeigaku; 2014; 54(12):1107-9. PubMed ID: 25672721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical profiles of Japanese patients with anti-NMDAR encephalitis and functional analysis of the anti-NMDAR antibodies].
    Tanaka K
    Rinsho Shinkeigaku; 2012; 52(11):985-7. PubMed ID: 23196492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune NMDA receptor encephalitis.
    Lazar-Molnar E; Tebo AE
    Clin Chim Acta; 2015 Jan; 438():90-7. PubMed ID: 25149104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients.
    Zhang Q; Tanaka K; Sun P; Nakata M; Yamamoto R; Sakimura K; Matsui M; Kato N
    Neurobiol Dis; 2012 Jan; 45(1):610-5. PubMed ID: 22008231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies.
    Ji T; Huang Z; Lian Y; Wang C; Zhang Q; Li J
    BMC Neurol; 2020 Sep; 20(1):336. PubMed ID: 32894089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
    Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
    J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology].
    Iizuka T; Sakai F
    Brain Nerve; 2008 Sep; 60(9):1047-60. PubMed ID: 18807939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody induced seizure susceptibility and impaired cognitive performance in a passive transfer rat model of autoimmune encephalitis.
    Pişkin ŞA; Korkmaz HY; Ulusoy CA; Şanlı E; Küçükali CI; Onat F; Tüzün E; Çarçak N
    Front Immunol; 2023; 14():1268986. PubMed ID: 38035091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.
    Mikasova L; De Rossi P; Bouchet D; Georges F; Rogemond V; Didelot A; Meissirel C; Honnorat J; Groc L
    Brain; 2012 May; 135(Pt 5):1606-21. PubMed ID: 22544902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-NMDAR autoimmune encephalitis.
    Miya K; Takahashi Y; Mori H
    Brain Dev; 2014 Sep; 36(8):645-52. PubMed ID: 24211006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
    Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
    Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABA
    Shen CH; Fang GL; Yang F; Cai MT; Zheng Y; Fang W; Guo Y; Zhang YX; Ding MP
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1392-1399. PubMed ID: 32710704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.
    Malter MP; Elger CE; Surges R
    Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis.
    Hughes EG; Peng X; Gleichman AJ; Lai M; Zhou L; Tsou R; Parsons TD; Lynch DR; Dalmau J; Balice-Gordon RJ
    J Neurosci; 2010 Apr; 30(17):5866-75. PubMed ID: 20427647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory loss and aberrant neurogenesis in mice exposed to patient anti-N-methyl-d-aspartate receptor antibodies.
    Taraschenko O; Fox HS; Heliso P; Al-Saleem F; Dessain S; Kim WY; Samuelson MM; Dingledine R
    Exp Neurol; 2024 Aug; 378():114838. PubMed ID: 38801989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.
    Schou M; Sæther SG; Borowski K; Teegen B; Kondziella D; Stoecker W; Vaaler A; Reitan SK
    Psychol Med; 2016 Dec; 46(16):3303-3313. PubMed ID: 27609625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.
    Liu CY; Zhu J; Zheng XY; Ma C; Wang X
    Mediators Inflamm; 2017; 2017():6361479. PubMed ID: 28698711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis.
    Moscato EH; Peng X; Jain A; Parsons TD; Dalmau J; Balice-Gordon RJ
    Ann Neurol; 2014 Jul; 76(1):108-19. PubMed ID: 24916964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune N-methyl-D-aspartate receptor encephalitis is a differential diagnosis of infectious encephalitis.
    Thomas L; Mailles A; Desestret V; Ducray F; Mathias E; Rogemond V; Didelot A; Marignier S; Stahl JP; Honnorat J;
    J Infect; 2014 May; 68(5):419-25. PubMed ID: 24355654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis.
    Mannara F; Radosevic M; Planagumà J; Soto D; Aguilar E; García-Serra A; Maudes E; Pedreño M; Paul S; Doherty J; Quirk M; Dai J; Gasull X; Lewis M; Dalmau J
    Brain; 2020 Sep; 143(9):2709-2720. PubMed ID: 32830245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.